These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31032905)

  • 1. Regulation of regulatory T cells in cancer.
    Stockis J; Roychoudhuri R; Halim TYF
    Immunology; 2019 Jul; 157(3):219-231. PubMed ID: 31032905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.
    Yano H; Andrews LP; Workman CJ; Vignali DAA
    Immunology; 2019 Jul; 157(3):232-247. PubMed ID: 31087644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking the Complexities of Tumor-Associated Regulatory T Cells.
    Chao JL; Savage PA
    J Immunol; 2018 Jan; 200(2):415-421. PubMed ID: 29311383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treg programming and therapeutic reprogramming in cancer.
    Moreno Ayala MA; Li Z; DuPage M
    Immunology; 2019 Jul; 157(3):198-209. PubMed ID: 30866047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T Cells in Autoimmunity and Cancer: A Duplicitous Lifestyle.
    Hatzioannou A; Boumpas A; Papadopoulou M; Papafragkos I; Varveri A; Alissafi T; Verginis P
    Front Immunol; 2021; 12():731947. PubMed ID: 34539668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remodeling of the tumor microenvironment via disrupting Blimp1
    Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
    Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells in cancer: where are we now?
    Gallimore A; Quezada SA; Roychoudhuri R
    Immunology; 2019 Jul; 157(3):187-189. PubMed ID: 31225653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide 3-kinaseĀ Ī“ is a regulatory T-cell target in cancer immunotherapy.
    Lim EL; Okkenhaug K
    Immunology; 2019 Jul; 157(3):210-218. PubMed ID: 31107985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.
    Colbeck EJ; Hindley JP; Smart K; Jones E; Bloom A; Bridgeman H; McPherson RC; Turner DG; Ladell K; Price DA; O'Connor RA; Anderton SM; Godkin AJ; Gallimore AM
    Oncotarget; 2015 Sep; 6(28):24649-59. PubMed ID: 26433463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
    Noman MZ; Hasmim M; Messai Y; Terry S; Kieda C; Janji B; Chouaib S
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C569-79. PubMed ID: 26310815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
    Luo CT; Liao W; Dadi S; Toure A; Li MO
    Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
    Yoshida K; Okamoto M; Sasaki J; Kuroda C; Ishida H; Ueda K; Ideta H; Kamanaka T; Sobajima A; Takizawa T; Tanaka M; Aoki K; Uemura T; Kato H; Haniu H; Saito N
    BMC Cancer; 2020 Jan; 20(1):25. PubMed ID: 31914969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells and innate immune regulation in tumor immunity.
    Wang RF
    Springer Semin Immunopathol; 2006 Aug; 28(1):17-23. PubMed ID: 16838179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid.
    Watson MJ; Vignali PDA; Mullett SJ; Overacre-Delgoffe AE; Peralta RM; Grebinoski S; Menk AV; Rittenhouse NL; DePeaux K; Whetstone RD; Vignali DAA; Hand TW; Poholek AC; Morrison BM; Rothstein JD; Wendell SG; Delgoffe GM
    Nature; 2021 Mar; 591(7851):645-651. PubMed ID: 33589820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets.
    van Herk EH; Te Velde AA
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1393-404. PubMed ID: 26990130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells and Toll-like receptors in tumor immunity.
    Wang RF; Peng G; Wang HY
    Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiles of regulatory T cells in the tumour microenvironment.
    Rao D; Verburg F; Renner K; Peeper DS; Lacroix R; Blank CU
    Cancer Immunol Immunother; 2021 Sep; 70(9):2417-2427. PubMed ID: 33576875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target.
    Hashemi V; Maleki LA; Esmaily M; Masjedi A; Ghalamfarsa G; Namdar A; Yousefi M; Yousefi B; Jadidi-Niaragh F
    Int Immunopharmacol; 2020 Jan; 78():106087. PubMed ID: 31841758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.